SPM™ is a bio-composition where cell activating ingredients are effectively compounded
SPM™ is the key outcome of 12 years of scientific research by BIOCOZ GLOBAL, which will provide an alternative to conventional cell treatment therapies.
SPM™ is a bio-composition containing recombinant human protein. It is a safe and effective composition for cell growth and regeneration.
SPM™ consists of biochemical substances such as amino acids, inorganic salts, vitamins, and human-derived proteins, all of which are already existing in the human body.
Unlike conventional bioproducts, SPMTM consists of 100% biochemically identified components, so there is a significantly low risk of component uncertainty or deformation. No side effects were observed such as drug resistance or the risk of immune deficiency.
SPM™ has a therapeutic mechanism such as promoting cell proliferation and extracellular matrix generation, which support wound recovery and skin regeneration.
Another therapeutic efficacy of SPM™ is the regulation of inflammatory response.
SPM™ has synergistic properties when applied with key substances that aid cell regeneration and tissue formation.
BIOCOZ GLOBAL is in the process of conducting an ascertaining study to further identify such properties of SPM™.
Efficacy and safety have been demonstrated in preliminary case studies for burns, diabetic foot ulcers and corneal diseases.
We are conducting pre-clinical tests with eczema and psoriasis patients.
We are conducting pre-clinical tests with atopic dermatitis patients.
BIOCOZ GLOBAL is developing commercialized therapeutic products, targeting specific diseases including immune-mediated disease, eczema, chronic skin diseases, and corneal diseases.
Diabetes Skin Care
Severe Burn Care